VanEck has appointed Dominic Jacobson as an Analyst for its Emerging Markets Equity Strategy.
In this newly created position, Jacobson will focus on the technology and healthcare sectors across all of the emerging markets regions. He joins a VanEck team led by Portfolio Manager David Semple, who has overseen this strategy, which includes the VanEck Emerging Markets Fund (GBFAX), since joining VanEck in 1998.
“Emerging markets have transformed over the last 20 years, driven by demographic changes, urbanisation, advances in technology, and a rising middle class. We’re thrilled to welcome Dominic to our team and to start leveraging his insights into the emerging markets tech and healthcare spaces,” says Semple. “Our strategy, which seeks out secular growth trends, skews toward the small- and mid-cap emerging markets stock universe. As such, a research-driven approach is essential to uncovering opportunities to add stocks poised for ‘growth at a reasonable price’ (GARP) and Dominic will no doubt play an important role in those efforts.”
Jacobson joins a team that, in addition to David Semple, includes a number of other analysts and investment professionals who collectively have more than four decades of experience living, investing, and working in emerging markets.
Prior to joining VanEck, Jacobson served as both Global Healthcare Analyst and North Asian Technology Analyst with Gavekal Capital. He was also the co-founder of Crowd Power Plant Ltd., an electricity supplier start-up in London. He earned a Master’s degree in Chemistry from the Imperial College London and BSc in Chemistry (with Honours) from the University of Edinburgh.
